Transcathater Arterial Chemoembolization in the Prevention of Postoperative Recurrence in Patients with Hepatocellular Carcinoma
LI Gui-hu
Abstract
LI Gui-hu
Abstract
Objective To evaluate the effect of transcathater arterial chemoembolization(TACE) in preventing postoperative recurrence of hepatocellular carcinoma and provide evidence to decrease the postoperative recurrence.Methods A total of 158 patients with hepatocellular carcinoma who received complete surgical removal were studied.Eighty-four cases receiving TACE at 30 days after surgery were TACE group and the remaining 74 cases without TACE were control group.All patients were follow-upped in the outpatient department or by telephone.The 1-,2-and 3-year cumulative recurrence rate and 1-,2-and 3-year cumulative survival rate of the two groups were compared.Results The follow-up rate was 95.2% in TACE group,and 95.9% in control group.The 1-,2-,and 3-year cumulative recurrence rates were 10.0%,45.0%,67.5% in TACE group,and 45.1%,66.2%,84.5% in control group.The differences were statistically significant(P0.05).The 1-,2-,3-year cumulative survival rates were 85.0%,72.5%,62.5% in TACE group and 70.4%,56.3%,45.1% in control group.The differences were statistically significant(P0.05).ConclusionPostoperative TACE avails to early detect the residual foci,reduce the recurrence rate and improve patients' survival rate.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effect of transcathater arterial chemoembolization(TACE) in preventing postoperative recurrence of hepatocellular carcinoma and provide evidence to decrease the postoperative recurrence.Methods A total of 158 patients with hepatocellular carcinoma who received complete surgical removal were studied.Eighty-four cases receiving TACE at 30 days after surgery were TACE group and the remaining 74 cases without TACE were control group.All patients were follow-upped in the outpatient department or by telephone.The 1-,2-and 3-year cumulative recurrence rate and 1-,2-and 3-year cumulative survival rate of the two groups were compared.Results The follow-up rate was 95.2% in TACE group,and 95.9% in control group.The 1-,2-,and 3-year cumulative recurrence rates were 10.0%,45.0%,67.5% in TACE group,and 45.1%,66.2%,84.5% in control group.The differences were statistically significant(P0.05).The 1-,2-,3-year cumulative survival rates were 85.0%,72.5%,62.5% in TACE group and 70.4%,56.3%,45.1% in control group.The differences were statistically significant(P0.05).ConclusionPostoperative TACE avails to early detect the residual foci,reduce the recurrence rate and improve patients' survival rate.
Key concepts: Medicine, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Surgery, Internal medicine, Gastroenterology, Survival rate, Carcinoma